Policy | August 03, 2022
PIB: Pharmaceutical industry in Maharashtra
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Manamed, a pioneering Medical Technology development company, has been granted FDA approval on its latest orthopaedic recovery device, ManaSport.
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Subscribe To Our Newsletter & Stay Updated
